Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.2700
-0.0220 (-7.53%)
Feb 5, 2026, 5:12 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 232.54 million as of February 5, 2026. Its market cap has increased by 7.03% in one year.
Market Cap
232.54M
Enterprise Value
229.16M
Revenue
2.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 232.54M, an increase of 124.29%. That is a compound annual growth rate of 8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 232.54M | 17.05% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 329.86M |
| Mendus AB | 309.84M |
| Lipum AB | 294.85M |
| Intervacc AB | 293.78M |
| Bio-Works Technologies AB | 278.39M |
| Elicera Therapeutics AB | 248.99M |
| Magle Chemoswed Holding AB | 235.40M |
| AlzeCure Pharma AB | 228.68M |